PATH Stock Recent News
PATH LATEST HEADLINES
PATH's enterprise AI edge and valuation advantage over APP make it the smarter buy in this AI-driven tech faceoff.
PATH jumps 36% in three months as strong partnerships, solid growth and discounted valuation draw investor interest.
PATH trades at a discounted 4.37X forward P/S, making it look undervalued versus peers amid solid revenue and RPA growth.
UiPath Inc. (NYSE:PATH ) Mizuho Technology Conference 2025 Call June 11, 2025 2:05 PM ET Company Participants Ashim Gupta - CFO & COO Conference Call Participants Sitikantha Panigrahi - Mizuho Securities USA LLC, Research Division Sitikantha Panigrahi All right. I'm Siti Panigrahi, software analyst here at Mizuho.
UiPath Inc. PATH stock has declined 10% in the past six months while gaining 12% in the past three months, indicating that the tide is turning.
PATH rides strong enterprise demand and key tech alliances to stay ahead in the fast-growing RPA market.
UiPath (PATH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The automation-software company pushed back on fears that cuts in U.S. federal spending may hurt its financial results.
UiPath's low expectations and improving fundamentals set up an attractive risk-reward, with revenue growth likely to accelerate into the mid-teens. The company boasts a strong balance sheet—over $1.5 billion in cash, no debt, and robust free cash flow, supporting a 17x forward FCF valuation. Recent product launches and partnerships with Microsoft and Google Cloud validate UiPath's near-term prospects and potential for renewed momentum.